BenzingaUpcoming Tocagen IPO To Finance Gene Therapy Clinical Trials …BenzingaThe biotech firm Tocagen Inc. plans an Initial Public Offering to finance ongoing clinical trials of a technique that uses a weaponized virus to help the …and more &… Continue reading
MIT Technology ReviewDetermined Parents are Moving the Needle on Gene Therapy – MIT …MIT Technology ReviewFamilies of patients are starting advocacy groups, raising money for research, and founding biotech companies to advance cures for rare diseases… Continue reading
|
CRISPR/Cas9 Reveals Cancer’s Synthetic Lethal Vulnerabilities
Genetic Engineering & Biotechnology News The CRISPR/Cas9 gene-editing system has been used to identify more than 120 synthetic-lethal gene interactions in cancer cells. These interactions could guide drug developers to new combination therapies that could selectively kill cancer cells, and … |
Immuno-Oncology News |
Trial Aimed at Helping Bladder Cancer Patients Choose Immunotherapy or Surgery
Immuno-Oncology News Patients with bladder cancer often have to choose between surgical removal of their bladder or a three-year course of the immunotherapy Bacillus Calmette-Guérin (BCG), which most people know as the tuberculosis vaccine. The two options have never been … |
Immuno-Oncology News |
Trial Aimed at Helping Bladder Cancer Patients Choose Immunotherapy or Surgery
Immuno-Oncology News Patients with bladder cancer often have to choose between surgical removal of their bladder or a three-year course of the immunotherapy Bacillus Calmette-Guérin (BCG), which most people know as the tuberculosis vaccine. The two options have never been … |